Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 742-752

  Chaduvula, Mehervani ^a   Murtaza, A ^b,e   Misra, Namita ^b,f   Shankar Narayan, N P ^c   Ramesh, V ^a   Prasad, H K ^b   Rani, Rajni ^d   Chinnadurai, R K ^a   Nath, Indira ^a,b  

^a SAFDARJUNG HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c VHS Leprosy Project   (India)

^d NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^e ABBOTT LABORATORIES   (United States)

^f L'Oreal Research and Innovation   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; C PEPTIDE; EPITOPE; GAMMA INTERFERON; LSR2 PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ADULT; ANALYSIS OF VARIANCE; ANERGIC LEPROMATOUS LEPROSY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDEMIC DISEASE; FEMALE; HUMAN; IMMUNE RESPONSE; LEPROMATOUS LEPROSY; LUNG TUBERCULOSIS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM LEPRAE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOID LEPROSY;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; HLA-DQ ALPHA-CHAINS; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; LEPROSY, LEPROMATOUS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; YOUNG ADULT;

EID: 84857185361     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05384-11     Document Type: Article

References (42)

1. Brahmbhatt S, et al. 2002. Human T cell responses to peptides of the Mycobacterium leprae 45-kD serine-rich antigen. Clin. Exp. Immunol. 128:140-148.
2. Chen JM, et al. 2006. Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis. J. Bacteriol. 188:633-641.
3. Chen JM, et al. 2008. Lsr2 of Mycobacterium tuberculosis is a DNAbridging protein. Nucleic Acids Res. 36:2123-2135.
4. Cho SN, Yanagihara DL, Hunter SW, Gelber RH, Brennan PJ. 1983. Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy. Infect. Immun. 41:1077-1083.
5. Colangeli R, et al. 2007. Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis. PLoS Pathog. 3:e87.
6. Cole ST, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
7. Cole ST, et al. 2001. Massive gene decay in the leprosy bacillus. Nature 409:1007-1011.
8. Coros A, Callahan B, Battaglioli E, Derbyshire KM. 2008. The specialized secretory apparatus ESX-1 is essential for DNA transfer in Mycobacterium smegmatis. Mol. Microbiol. 69:794-808.
9. Fernandez-Vina MA, et al. 1991. Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups. Immunogenetics. 34:299-312.
10. Gordon BR, et al. 2011. Structural basis for recognition of AT-rich DNA by unrelated xenogeneic silencing proteins. Proc. Natl. Acad. Sci. U. S. A. 108:10690-10695.
11. Gordon BR, et al. 2010. Lsr2 is a nucleoid-associated protein that targets AT-rich sequences and virulence genes in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 107:5154-5159.
12. Haregewoin A, Godal T, Mustafa AS, Belehu A, Yemaneberhan T. 1983. T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy. Nature 303:342-344.
13. Houghten RA. 1985. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. U. S. A. 82:5131-5135.
14. Hunter SW, Brennan PJ. 1981. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J. Bacteriol. 147:728-735.
15. Kaplan G, Mathur NK, Job CK, Nath I, Cohn ZA. 1989. Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae. Proc. Natl. Acad. Sci. U. S. A. 86:8073-8077.
16. Kumar S, Naqvi RA, Khanna N, Rao DN. 2011. Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy. Mol. Immunol. 48:1178-1190.
17. Laal S, Bhutani LK, Nath I. 1985. Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum. Infect. Immun. 50:887-892.
18. Laal S, et al. 1991. Recombinant fusion protein identified by lepromatous sera mimics native Mycobacterium leprae in T-cell responses across the leprosy spectrum. Proc. Natl. Acad. Sci. U. S. A. 88:1054-1058.
19. Li S, Sjogren HO, Hellman U, Pettersson RF, Wang P. 1997. Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. U. S. A. 94:8708-8713.
20. Misra N, et al. 1995. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology 86:97-103.
21. Nath I, Mehervani C. 2010. Immunological aspects. Jaypee Brothers Medical Publishers (P), Ltd., New Delhi, India.
22. Nath I, et al. 1990. Human immune response to recombinant interferon gamma and protein antigen LSR2. Trop. Med. Parasitol. 41:324-325.
23. Nath I, Sathish M, Jayaraman T, Bhutani LK, Sharma AK. 1984. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy. Clin. Exp. Immunol. 58:522-530.
24. Nath I, Van Rood JJ, Mehra NK, Vaidya MC. 1980. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses. Clin. Exp. Immunol. 42:203-210.
25. Oftung F, Lundin KE, Meloen R, Mustafa AS. 1999. Human T cell recognition of the Mycobacterium leprae LSR antigen: epitopes and HLA restriction. FEMS Immunol. Med. Microbiol. 24:151-159.
26. Ottenhoff TH, et al. 1986. Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Nature 319:66-68.
27. Rani R, Fernandez-Vina MA, Zaheer SA, Beena KR, Stastny P. 1993. Study of HLA class II alleles by PCR oligotyping in leprosy patients from north India. Tissue Antigens 42:133-137.
28. Rani R, Mukherjee R, Stastny P. 1998. Diversity of HLA-DR2 in North Indians: the changed scenario after the discovery of DRB1*1506. Tissue Antigens 52:147-152.
29. Ridley DS, Jopling WH. 1966. Classification of leprosy according to immunity.Afive-group system. Int. J. Lepr. Other Mycobact. Dis. 34:255-273.
30. Scollard DM, et al. 2006. The continuing challenges of leprosy. Clin. Microbiol. Rev. 19:338-381.
31. Sela S, Thole JE, Ottenhoff TH, Clark-Curtiss JE. 1991. Identification of Mycobacterium leprae antigens from a cosmid library: characterization of a 15-kilodalton antigen that is recognized by both the humoral and cellular immune systems in leprosy patients. Infect. Immun. 59:4117-4124.
32. Sharma P, et al. 2000. Mycobacterium w vaccine, a useful adjuvant to multidrug therapy in multibacillary leprosy: a report on hospital based immunotherapeutic clinical trials with a follow-up of 1-7 years after treatment. Lepr. Rev. 71:179-192.
33. Singh S, et al. 1994. Critical residues of the Mycobacterium leprae LSR recombinant protein discriminate clinical activity in erythema nodosum leprosum reactions. Infect. Immun. 62:5702-5705.
34. Singh S, et al. 1994. Sera of leprosy patients with type 2 reactions recognize selective sequences in Mycobacterium leprae recombinant LSR protein. Infect. Immun. 62:86-90.
35. Spencer JS, et al. 2005. Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J. Immunol. 175:7930-7938.
36. Spencer JS, et al. 2004. Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10. Infect. Immun. 72:3161-3170.
37. Sreenivasan P, Misra RS, Wilfred D, Nath I. 1998. Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions. Immunology 95:529-536.
38. Stanford JL, et al. 1989. Vaccination and skin test studies on the children of leprosy patients. Int. J. Lepr. Other Mycobact. Dis. 57:38-44.
39. Talwar GP, et al. 1990. Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients. Vaccine 8:121-129.
40. WHO. 2010. Global leprosy situation, 2010. Wkly. Epidemiol. Rec. 85: 337-348.
41. Wong DK, Lee BY, Horwitz MA, Gibson BW. 1999. Identification of fur, aconitase, and other proteins expressed by Mycobacterium tuberculosis under conditions of low and high concentrations of iron by combined twodimensional gel electrophoresis and mass spectrometry. Infect. Immun. 67:327-336.
42. Young RA, et al. 1985. Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature 316:450-452.